UMIN ID: C000000373
Registered date:01/04/2006
Lisinopril for IgA nephropathy with focal mesangial proliferation in children
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | IgA nephropathy in children |
| Date of first enrollment | 1998/08/01 |
| Target sample size | 50 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Lisinopril for 2 years |
Outcome(s)
| Primary Outcome | Disappearance rate of proteinuria |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 2years-old |
|---|---|
| Age maximum | 18years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1.Other renal or systemic forms defined on renal biopsy, clinical features or serology (Henoch-Schönlein nephritis, systemic lupus erythematosus). 2.Medical history of allergy or hypersensitivity reactions to lisinopuril. 3.Chronic renal dysfunction. 4.Active infectious disease. 5.Severe liver disfunction. 6.History of steroid, immunosupression, ACEI, ARB, Saireito and dipilidamol administration. 7.Pregnancy. 8.Judged inappropriate for this study by the physicians. |
Related Information
| Primary Sponsor | The Japanese Pediatric IgA Nephropathy of Treatment Study Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | The Kidney Foundation, Japan |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| Affiliation | The Japanese Pediatric IgA Nephropathy of Treatment Study Group Department of Pediatrics, Wakayama Medical University |
| scientific contact | |
| Name | Norishige Yoshikawa |
| Address | 811-1 Kimiidera Wakayama City Wakayama Japan |
| Telephone | |
| Affiliation | Wakayama Medical University Department of Pediatrics |